A comprehensive review and meta-analysis of risk factors for statin-induced myopathy Khoa A. NguyenLang LiTitus K. Schleyer Review 22 May 2018 Pages: 1099 - 1109
Antiviral prophylaxis during chemotherapy or immunosuppressive drug therapy to prevent HBV reactivation in patients with resolved HBV infection: a systematic review and meta-analysis Yi-Chia SuPei-Chin LinChih-Chien Wu Review 29 May 2018 Pages: 1111 - 1119
Pharmacodynamic interaction between intravenous nitroglycerin and oral sacubitril/valsartan (LCZ696) in healthy subjects Uwe SchuehlySurya AyalasomayajulaThomas H. Langenickel Pharmacodynamics 04 July 2018 Pages: 1121 - 1130
Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles Jing LinZhao HanRuyue Huang Pharmacoeconomics 26 May 2018 Pages: 1131 - 1140
Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function Renli TengSharen MuldowneyNaeem D. Khan Pharmacokinetics and Disposition Open access 30 May 2018 Pages: 1141 - 1148
Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study Byung Hak JinByung Won YooMin Soo Park Pharmacokinetics and Disposition Open access 30 May 2018 Pages: 1149 - 1157
Are multidose drug dispensing systems initiated for the appropriate patients? Bram J. MertensH. F. KwintMarcel L. Bouvy Pharmacoepidemiology and Prescription Open access 16 May 2018 Pages: 1159 - 1164
Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs Diana M RydbergStefan MejyrRickard E Malmström Pharmacoepidemiology and Prescription Open access 27 May 2018 Pages: 1165 - 1173
Hormonal contraception is not associated with increased risk for seizures in the general population: results from a cohort study using The Health Improvement Network Christoph Patrick BeierLuis A. García RodríguezAntonio González-Pérez Pharmacoepidemiology and Prescription 31 May 2018 Pages: 1175 - 1180
Tamoxifen and the risk of Parkinsonism: a case/non-case study François MontastrucFarzin Khosrow-KhavarJean-Louis Montastruc Pharmacoepidemiology and Prescription 03 June 2018 Pages: 1181 - 1184
Prevalence of use of antipsychotic drugs in the elderly in Catalonia Carmen AsensioNúria EscodaJoan-Ramon Laporte Letter to the Editor 23 May 2018 Pages: 1185 - 1186
Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans? Shingen MisakaKenju Shimomura Letter to the Editor 17 May 2018 Pages: 1187 - 1188
Response: Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans? Satish Kumar BedadaPrasad Neerati Letter to the Editor 13 May 2018 Pages: 1189 - 1190
Acute kidney injury, agranulocytosis, drug-induced liver injury, and posterior reversible encephalopathy syndrome caused by high-dose methotrexate—possible role of low activity ABC and SLC drug transporters L. BielenI. KraljN. Božina Letter to the Editor 22 May 2018 Pages: 1191 - 1192
Pharmacokinetics of imipenem in plasma and cerebrospinal fluid in patients with intracerebral hemorrhage Lingti KongHongzhou XuXiaofei Wu Letter to the Editor 24 May 2018 Pages: 1193 - 1195
The race for drug approvals: hasten slowly? Alain Braillon Letter to the Editor 22 May 2018 Pages: 1197 - 1198
Response to the letter to the Editor regarding Zeukeng et al.’s article A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs Minette-Joëlle ZeukengEnrique Seoane-VazquezPascal Bonnabry Letter to the Editor 26 May 2018 Pages: 1199 - 1200